Patents by Inventor Bruce Zuraw

Bruce Zuraw has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THRESHOLD-STIMULATED PLASMA KALLIKREIN ACTIVITY AS A BIOMARKER FOR DIAGNOSIS OF BRADYKININ-MEDIATED ANGIOEDEMA
    Publication number: 20200407771
    Abstract: Provided is a diagnostic test for the positive identification of patients with bradykinin-mediated angioedema. The test is valuable for distinguishing bradykinin-mediated angioedema from non-bradykinin-mediated angioedema. The test allows clinicians to clearly separate patients with bradykinin-mediated from histamine-mediated angioedema. Results can be obtained in under an hour, allowing for the proper treatment of angioedema based on the underlying etiology.
    Type: Application
    Filed: February 22, 2019
    Publication date: December 31, 2020
    Inventors: Bruce Zuraw, Maria Luz Lara-Marquez
  • Methods for increasing C1 inhibitor concentrations using interferon-gamma and/or interleukin-6
    Patent number: 5271931
    Abstract: The present invention relates to the use of interferon and/or interleukin-6 to increase intravascular C1 inhibitor concentrations in patients exhibiting or at risk for a C1 inhibitor deficiency. Therapeutic compositions containing interferon and/or interleukin-6 are also disclosed.
    Type: Grant
    Filed: September 14, 1988
    Date of Patent: December 21, 1993
    Assignee: The Scripps Research Institute
    Inventors: Martin Lotz, Bruce Zuraw, Dennis A. Carson